Personalized Medicine through Genomic Analysis and Molecular Diagnostics
March 31, 2008
Enter “CONNEXON” at checkout and receive 10% off registration.
Click here to register today.
Fluorescent Chinese Pig Passes on Trait to Offspring
A pig genetically modified in China to make it glow has given birth to fluorescent piglets, proving such changes can be inherited.
Stem Cell Technique Wins U.S. Funding, Fuels Debate
The National Institutes of Health began accepting grant applications Jan. 5 from scientists studying an advance reported in November.
New Insight Into Factors That Drive Muscle-building Stem Cells
There is a new explanation for how stem cells known as satellite cells contribute to building muscles up in response to exercise.
Protein in Human Hair Shows Promise for Regenerating Nerves
A protein found in human hair shows promise for promoting the regeneration of nerve tissue and could lead to a new treatment option when nerves are cut or crushed from trauma.
Researchers Use Magnetism to Target Cells to Animal Arteries
Scientists have used magnetic fields and tiny iron-bearing particles to drive healthy cells to targeted sites in blood vessels.
Pluristem Announces Second Clinical Indication Revascularization Effect After PLX-PAD Therapy
Pluristem Therapeutics Inc. has announced that it has identified a second clinical indication for its proprietary PLX cells and the expansion of its pipeline of PLX products. Pluristem’s PLX-PAD is expected to begin clinical trials in the second half of 2008 in Europe for the treatment of limb ischemia associated with peripheral artery disease (PAD).
Gene Therapy Gets Injured Mice Moving Again
A combination of gene therapy and tissue grafts could offer an improved way to repair ruptured tendons and ligaments, including common sports injuries such as season-ending knee and shoulder problems, according to a new study in mice.
Sangamo BioSciences Initiates Phase 2 Clinical Trial of ZFP Therapeutic in Stem Cell Mobilization
Sangamo BioSciences, Inc. has announced the initiation of a randomized, single-blind, placebo-controlled, multi-center Phase 2 clinical trial in subjects with mild to moderate diabetic neuropathy.
A Dog’s Stem Cell Life
In the race to perfect “regenerative medicine,” stem cell therapy for animals is ahead of treatment for humans because it is not so strictly regulated. It’s not experimental – it’s here.
Japan Researcher Proposes Stem Cell Bank
Creating a bank to store a new type of stem cell produced from donors’ ordinary skin cells could help reduce time and money for treating patients with regenerative medicine in the future.
China Offers Unproven Medical Treatments
Western doctors warn that patients are serving as guinea pigs in a country that isn’t doing the rigorous lab and human tests that are needed to prove a treatment is safe and effective.
China Parents to Sue Over “Tainted” Umbilical Blood
Scores of Shanghai parents are to sue a biotech firm suspected of concealing the fact that their children’s umbilical cord blood, believed to be a likely cure for future blood diseases, was tainted.
ABSTRACTS, REVIEWS AND SPECIAL REPORTS
Human Embryonic Stem Cell-Derived Dopaminergic Neurons Reverse Functional Deficit in Parkinsonian Rats
The researchers show that human embryonic stem cell-derived dopaminergic neurons survived transplantation to the neurotoxin 6-hydroxydopamine-lesioned rat striatum and, in combination with the cells newly differentiated from their progenitors, contributed to locomotive function recovery at 5 months.
Cell Therapy Business Development Leader
Portland, OR (Invitrogen)
Irvine, CA (Global Biopharmaceutical Company)
Biomedical Equipment Technician
Los Angeles, CA (Cedars-Sinai Medical Center)
Singapore (Singapore Cord Blood Bank)